glucagon

The FDA has approved GVOKE, a glucagon injection for the treatment of dangerously low blood sugar (severe hypoglycemia) in people with diabetes who are at least two years of age. Xeris Pharmaceutical’s GVOKE is room-temperature, liquid, stable glucagon that is ready-to-use in an emergency. It...

The U.S. Food and Drug Administration (FDA) has approved Lilly’s BAQSIMI (glucagon) nasal powder 3 mg for the treatment of severe hypoglycemia in people with diabetes ages four years and above. BAQSIMI is the first and only nasally administered glucagon, and it was designed with severe...

When people talk about diabetes, they usually also talk about insulin. Diabetes is a disease that affects millions of people around the world; insulin is a hormone that helps control this disease. Now a third term could soon be joining the conversation: glucagon. Glucagon has long been seen as...

Eli Lilly and Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) and an EU Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for nasal glucagon. If the drug receives approval, it will be the first dry powder nasal...

Last year I took part in a research programme to help ADULTS with very poor hypo awareness and they now have funding to trial this programme in London, Sheffield and Bournemouth and are seeking participants with type 1 diabetes who need help in restoring hypo awareness. It involves attending...

Arecor, the company on Chesterton Research Park developing better treatments for diabetes, has been awarded a £1.05m government grant to help push ahead to early stage clinical trials. The biotech company is reformulating proteins and peptides to improvement treatment for other ills as well as...

Blocking the hormone that raises sugar levels in the blood could increase insulin levels while keeping blood sugar levels down. The findings in mice, to be published in eLife, point to a novel way to treat diabetes -- but only in some patients. They also challenge the benefits of the strategy...

In 2015, the pharmaceutical company Zosano Pharma conducted a Phase II trial on a glucagon patch to test the patch’s safety and efficiency. The small trial, which represented an important step forward towards getting FDA approval, yielded positive results. Researchers found that applying two...

A recent study has shown that a powdered form of glucagon that can be administered as a nasal spray can rescue a hypo as quickly as injected glucagon. Glucagon is a hormone with the opposite action to insulin – it helps the body to increase blood glucose levels. This means people with type 1...